Foley & Larder LLP represented TCG Crossover, lead investor.Adverum Biotechnologies has agreed to sell approximately 106.25 million shares of its common stock at a price per share of…
Adverum Biotechnologies’ $127.5 Million Private Placement


Foley & Larder LLP represented TCG Crossover, lead investor.Adverum Biotechnologies has agreed to sell approximately 106.25 million shares of its common stock at a price per share of…
…